A narrative review of the current landscape and future perspectives of HER2-targeting antibody drug conjugates for advanced breast cancer
Authors:
Open Access
- 1 October 2021
- journal article
- review article
- Published by AME Publishing Company in Translational Breast Cancer Research
- Vol. 2, 29